Biohaven Environmental Solutions, LLC

LOS ANGELES, CA · CIK 0001592917 · Biotech

Pharmaceutical therapeutics for neurological and neuropsychiatric diseases

biohaven.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.4M
1 Form D · Dec 2013
154 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,400,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1820MBQ PHARMA INC.—$4.2M
1821NEUROPATHIX, INC.—$1.3M
1822CUMBERLAND PHARMACEUTICALS, INC.——
1823Biohaven Environmental Solutions, LLC—$1.4M
1824Discgenics, Inc.—$870K
1825Prairie Pharms, LLC—$455K
1826Magna Pharmaceuticals, Inc.—$1.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Burr O'ConnorExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.